SEARCH

SEARCH BY CITATION

References

  • Agarwal, V. and Khan, M. (2001) Current status of the oral delivery of insulin. Pharm. Technol., October , 7690.
  • American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31, 596615.
  • Arakawa, T., Yu, J., Chong, D.K., Hough, J., Engen, P.C. and Langridge, W.H. (1998) A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol., 16, 934938.
  • Arlen, P.A., Falconer, R., Cherukumilli, S., Cole, A., Cole, A.M., Oishi, K.K. and Daniell, H. (2007) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol. J., 5, 511525.
  • Arlen, P.A., Singleton, M., Adamovicz, J.J., Ding, Y., Davoodi-Semiromi, A. and Daniell, H. (2008) Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect. Immun., 76, 36403650.
  • Bally, J., Paget, E., Droux, M., Job, C., Job, D. and Dubald, M. (2008) Both the stroma and thylakoid lumen of tobacco chloroplasts are competent for the formation of disulphide bonds in recombinant proteins. Plant Biotechnol. J., 6, 4661.
  • Boothe, J., Nykiforuk, C., Shen, Y., Zaplachinski, S., Szarka, S., Kuhlman, P., Murray, E., Morck, D. and Moloney, M.M. (2010) Seed-based expression systems for plant molecular farming. Plant Biotechnol. J., 8, 588606.
  • Centers for Disease Control and Prevention (2008) National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
  • Daniell, H. (2007) Transgene containment by maternal inheritance: effective or elusive? Proc. Natl Acad. Sci. USA, 104, 68796880.
  • Daniell, H., Lee, S.-B., Panchal, T. and Wiebe, P.O. (2001) Expression of the Native Cholera Toxin B Subunit Gene and Assembly as Functional Oligomers in Transgenic Tobacco Chloroplasts. J. Mol. Biol., 311, 10011009.
  • Daniell, H., Singh, N., Mason, H. and Streatfield, S.J. (2009a) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci., 14, 669679.
  • Daniell, H., Ruiz, G., Denes, B., Sandberg, L. and Langridge, W. (2009b) Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function. BMC Biotechnol., 9, 33.
  • Davoodi-Semiromi, A., Samson, N. and Daniell, H. et al. (2009) The green vaccine: a global strategy to combat infectious and autoimmune diseases. Hum. Vaccin., 5, 488493.
  • Davoodi-Semiromi, A., Schreiber, M., Nalapalli, S., Verma, D., Singh, N.D., Banks, R.K., Chakrabarti, D. and Daniell, H. (2010) Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol. J., 8, 223242.
  • Dertzbaugh, M.T. and Cox, L. (1998) The affinity of cholera toxin for Ni2 +  ion. Protein Eng., 11, 577581.
  • Ekberg, K., Brismar, T., Johansson, B.L., Jonsson, B., Lindström, P. and Wahren, J. (2003) Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes, 52, 536541.
  • Fernandez-San Millan, A., Minego-Castel, A., Mingo-Castel, A., Miller, M. and Daniell, H. (2003) A chloroplast genetic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J., 1, 7179.
  • Fujimoto, K., Sasaki, T., Nemoto, M., Nakai, N., Sakai, K., Yamasaki, K., Hiki, Y., Ohashi, T., Eto, Y. and Tajima, N. (2005) Enhanced insulin secretion from engineered 3T3-L1 preadipocytes by induction of cellular differentiation. Mol. Cell. Biochem., 268, 18.
  • Giannini, C., Mohn, A. and Chiarelli, F. et al. (2009) Technology and the issue of cost/benefit in diabetes. Diabetes Metab. Res. Rev., 25(Suppl 1), S3444.
  • Groskreutz, D.J., Sliwkowski, M. and Gorman, C.M. (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J. Biol. Chem., 269, 62416245.
  • Gupta, S., Chattopadhyay, T., Singh, M.P. and Surolia, A. (2010) Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus. Proc. Natl Acad. Sci. USA, 107, 1324613251.
  • de Haan, L., Verweij, W., Agsteribbe, E. and Wilschut, J. (1998) The role of ADP-ribosylation and GM1-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin. Immunol. Cell Biol., 76, 270279.
  • Hills, C.E. and Brunskill, N. (2009) Cellular and physiological effects of C-peptide. Clin. Sci. (Lond), 116, 565574.
  • Iyer, H., Khedkar, A. and Verma, M. (2010) Oral insulin – a review of current status. Diabetes Obes. Metab., 12, 179185.
  • Jensen, R. (2000) Activation of Rubisco regulates photosynthesis at high temperature and CO2. Proc. Natl Acad. Sci., 97, 1293712938.
  • Johansson, B.L., Borg, K., Fernqvist-Forbes, E., Kernell, A., Odergren, T. and Wahren, J. (2000) Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet. Med., 1, 181189.
  • Kjeldsen, T. (2000) Yeast secretory expression of insulin precursors. Appl. Microbiol. Biotechnol., 54, 277286.
  • Koya, V., Moayeri, M., Leppla, S.H. and Daniell, H. (2005) Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun., 73, 82668274.
  • Krishnan, H.B. and Natarajan, S. (2009) A rapid method for depletion of Rubisco from soybean (Glycine max) leaf for proteomic analysis of lower abundance proteins. Phytochemistry, 70, 19581964.
  • Kumar, S. and Daniell, H. (2004) Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens. Methods Mol. Biol., 267, 365383.
  • Lee, S.B., Li, B., Jin, S. and Daniell, H. (2011) Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol. J. doi:10.1111/j.1467-7652.2010.00538.x
  • Levinson, P.D. (2003) Eighty years of insulin therapy: 1922-2002. Med. Health R. I., 86, 101106.
  • Li, D., O’Leary, J., Huang, Y., Huner, N.P., Jevnikar, A.M. and Ma, S. (2006) Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants. Plant Cell Rep., 25, 417424.
  • Liljeqvist, S., Stahl, S., Andréoni, C., Binz, H., Uhlén, M. and Murby, M. (1997) Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J. Immunol. Methods, 210, 125135.
  • Limaye, A., Koya, V., Samsam, M. and Daniell, H. (2006) Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J., 20, E37E46.
  • Martin, C. and Thimann, K. (1972) The role of protein synthesis in the senescence of leaves: I. The formation of protease. Plant Physiol., 49, 6471.
  • Oey, M., Lohse, M., Scharff, L.B., Kreikemeyer, B. and Bock, R. (2009) Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc. Natl Acad. Sci. USA, 106, 65796584.
  • Pekar, A.H. and Frank, B. (1972) Conformation of proinsulin. A comparison of insulin and proinsulin self-association at neutral pH. Biochemistry, 11, 40134016.
  • Pozzilli, P., Raskin, P. and Parkin, C.G. (2010) Review of clinical trials: update on oral insulin spray formulation. Diabetes Obes. Metab., 12, 9196.
  • Quesada-Vargas, T., Ruiz, O. and Daniell, H. (2005) Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation. Plant Physiol., 138, 17461762.
  • Raab, R., Fezeu, L. and Mbanya, J.C. (2004) Cost and availability of insulin and other diabetes supplies: IDF survey 2003–2003. Diabetes Voice, 49, 2429.
  • Rebsomen, L., Khammar, A., Raccah, D. and Tsimaratos, M. (2008) C-peptide effects on renal physiology and diabetes. Exp. Diabetes Res., 2008, 15.
  • Ruhlman, T., Ahangari, R., Devine, A., Samsam, M. and Daniell, H. (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J., 5, 495510.
  • Ruhlman, T., Verma, D., Samson, N. and Daniell, H. (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol., 152, 20882104.
  • Shaw, J.A.M., Delday, M., Hart, A.W., Docherty, H.M., Maltin, C.A. and Docherty, K. (2002) Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J. Endocrinol., 172, 653672.
  • Siekmeier, R. and Scheuch, G. (2008) Inhaled insulin--does it become reality? J. Physiol. Pharmacol., 59(Suppl 6), 81113.
  • Sima, A.A.F. and Li, Z.-G. (2005) The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes, 54, 14971505.
  • Steiner, D.F. (1998) The proprotein convertases. Curr. Opin. Chem. Biol., 2, 3139.
  • Suda, T., Katoh, M., Hiratsuka, M., Takiguchi, M., Kazuki, Y., Inoue, T. and Oshimura, M. (2006) Heat regulated production and secretion of insulin from a human artificial chromosome vector. Biochem. Biophys. Res. Commun., 340, 10531061.
  • Swartz, J.R. (2001) Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol., 12, 195201.
  • Tatake, R.J., O’neill, M.M., Kennedy, C.A., Reale, V.D., Runyan, J.D., Monaco, K.A., Yu, K., Osborne, W.R., Barton, R.W. and Schneiderman, R.D. (2007) Glucose-regulated insulin production from genetically engineered human non-beta cells. Life Sci., 81, 13461354.
  • Taylor, N.A., Van De Ven, W. and Creemers, J.W. (2003) Curbing activation: proprotein convertases in homeostasis and pathology. FASEB J., 17, 12151227.
  • Thomas, G. (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev., 3, 753766.
  • Tsuji, T., Watanabe, K. and Miyama, A. (1995) Monomer of the B Subunit of Heat-Labile Enterotoxin from Enterotoxigenic Escherichia coli Has Little Ability to Bind to GM1 Ganglioside Compared to Its Coligenoid. Microbiol. Immunol., 39, 817819.
  • Verma, D. and Daniell, H. (2007) Chloroplast Vector Systems for Biotechnology Applications. Plant Physiol., 145, 11291143.
  • Verma, D., Samson, N., Koya, V. and Daniell, H. (2008) A protocol for expression of foreign genes in chloroplasts. Nat. Protoc., 3, 739758.
  • Verma, D., Moghimi, B., LoDuca, P.A., Singh, H.D., Hoffman, B.E., Herzog, R.W. and Daniell, H. (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc. Natl Acad. Sci. USA, 107, 71017106.
  • Vierstra, R.D. (1993) Protein Degradation in Plants. Annu. Rev. Plant Physiol. Plant Mol. Biol., 44, 385410.
  • Wahren, J. (2004) “C-peptide: new findings and therapeutic implications in diabetes. Clin. Physiol. Funct. Imaging, 24, 180189.
  • Wahren, J., Ekberg, K. and Jörnvall, H. (2007) C-peptide is a bioactive peptide. Diabetologia, 50, 503509.
  • Williams, D.C., Van Frank, R.M., Muth, W.L. and Burnett, J.P. (1982) Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins. Science, 215, 687689.